Literature DB >> 25608999

[Therapy-resistant hypertension].

J Schrader1, S Lüders.   

Abstract

BACKGROUND: Therapy-resistant hypertension is commonly encountered in daily practice. It is present when the therapeutic goal is not achieved after trying at least three antihypertensives from different groups with adequate doses and including a diuretic. Between 10 and 20% of patients are affected and their prognosis is poor. Thus, intensive strategies are required to achieve normotension. DIAGNOSIS: An exact diagnosis is essential. Pseudoresistance needs to be excluded in addition to secondary hypertension and sleep apnea syndrome. The most common cause of pseudoresistance is incorrect blood pressure measurement, false estimation of the real blood pressure level, lack of compliance, unhealthy lifestyle, and drug interactions. Therapeutic resistance should not be diagnosed without 24 h ambulatory blood pressure measurement. This significantly reduces the total number of "resistant" patients. THERAPY: Successful control of blood pressure is achieved in the majority of patients by taking advantage of all possible therapy options. Treatment with 4-6 antihypertensive drugs is justified because of the improvement of cardiovascular prognosis. However, prerequisite is the absence of undesirable side effects which is the most important condition for adequate and reliable patient compliance. Only in the case of failure of the above therapy options can invasive procedures--renal denervation and baroreflex activation therapy--be applied as they are still experimental. Successful management of patients with resistant hypertension is only possible with intensive and time-consuming physician-patient relationships.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25608999     DOI: 10.1007/s00108-014-3644-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  28 in total

Review 1.  [Chronobiology of blood pressure and chronopharmacotherapy of arterial hypertension].

Authors:  R E Schmieder; P Bramlage; H Schunkert
Journal:  Dtsch Med Wochenschr       Date:  2012-02-08       Impact factor: 0.628

Review 2.  Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations.

Authors:  Dmitrij Achelrod; Ulrich Wenzel; Simon Frey
Journal:  Am J Hypertens       Date:  2014-08-25       Impact factor: 2.689

3.  Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use.

Authors:  Harneet K Walia; Hong Li; Michael Rueschman; Deepak L Bhatt; Sanjay R Patel; Stuart F Quan; Daniel J Gottlieb; Naresh M Punjabi; Susan Redline; Reena Mehra
Journal:  J Clin Sleep Med       Date:  2014-08-15       Impact factor: 4.062

4.  Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring.

Authors:  Alejandro de la Sierra; Julián Segura; José R Banegas; Manuel Gorostidi; Juan J de la Cruz; Pedro Armario; Anna Oliveras; Luis M Ruilope
Journal:  Hypertension       Date:  2011-03-28       Impact factor: 10.190

5.  [Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment].

Authors:  F Mahfoud; O Vonend; H Bruck; W Clasen; S Eckert; B Frye; H Haller; M Hausberg; U C Hoppe; J Hoyer; K Hahn; T Keller; B K Krämer; R Kreutz; S A Potthoff; H Reinecke; R Schmieder; V Schwenger; U Kintscher; M Böhm; L C Rump
Journal:  Dtsch Med Wochenschr       Date:  2011-11-02       Impact factor: 0.628

6.  Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort.

Authors:  David A Calhoun; John N Booth; Suzanne Oparil; Marguerite R Irvin; Daichi Shimbo; Daniel T Lackland; George Howard; Monika M Safford; Paul Muntner
Journal:  Hypertension       Date:  2013-12-09       Impact factor: 10.190

7.  Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications.

Authors:  Diana E Ayala; Ramón C Hermida; Artemio Mojón; José R Fernández
Journal:  Chronobiol Int       Date:  2012-10-19       Impact factor: 2.877

Review 8.  Treatment resistant hypertension--investigation and conservative management.

Authors:  Franz Weber; Manfred Anlauf
Journal:  Dtsch Arztebl Int       Date:  2014-06-20       Impact factor: 5.594

9.  The contributions of unhealthy lifestyle factors to apparent resistant hypertension: findings from the Reasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Authors:  Daichi Shimbo; Emily B Levitan; John N Booth; David A Calhoun; Suzanne E Judd; Daniel T Lackland; Monika M Safford; Suzanne Oparil; Paul Muntner
Journal:  J Hypertens       Date:  2013-02       Impact factor: 4.844

10.  High prevalence of masked uncontrolled hypertension in people with treated hypertension.

Authors:  José R Banegas; Luis M Ruilope; Alejandro de la Sierra; Juan J de la Cruz; Manuel Gorostidi; Julián Segura; Nieves Martell; Juan García-Puig; John Deanfield; Bryan Williams
Journal:  Eur Heart J       Date:  2014-02-03       Impact factor: 29.983

View more
  2 in total

Review 1.  [Antihypertensive therapy in the elderly].

Authors:  J Schrader; B Schrader
Journal:  Herz       Date:  2018-05       Impact factor: 1.443

2.  [Therapy-resistant and therapy-refractory arterial hypertension].

Authors:  M Wallbach; M J Koziolek
Journal:  Internist (Berl)       Date:  2018-06       Impact factor: 0.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.